Protirelin

Records for this ingredient, by country (identity only).

ATC V04CJ02 · 4 markets · 19 records

Protirelin 4 markets · 19 records Forms
Filters
MarketJP 9GB 4FR 1

JP 9 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 0.5 mg per mL / per unit basis not statedinjectionTRH注0.5mg「ニプロ」ヒルトニン0.5mg注射液、プロチレリン酒石酸塩注2mg「NP」、プロチレリン酒石酸塩注射液2mg「SW」
  • 2 mg/1 mLinjectionヒルトニン2mgプロチレリン酒石酸塩注2mg「NP」、プロチレリン酒石酸塩注射液2mg「SW」
  • 1 mg/1 mLinjectionヒルトニン1mgプロチレリン酒石酸塩注射液2mg「サワイ」

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 2 mL per mL / per unit basis not statedinjectionManufacturer: A A H Pharmaceuticals LtdManufacturer: Alliance Healthcare (Distri…、Manufacturer: Alliance Pharmaceuticals Ltd
  • 1 mL per mL / per unit basis not statedinjectionManufacturer: Special Order

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 0.2 mg/1 mLinjectionTRH FERRING 200 microgrammes/1 ml, solution injectable

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.